Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.
- NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_assertion wasGeneratedBy ECO_0000203 NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.
- NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_assertion wasDerivedFrom befree-2016 NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.
- NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_assertion SIO_000772 24311521 NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.
- NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_assertion evidence source_evidence_literature NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.
- NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_assertion description "[Outside of tumor entities for which targeted drugs are already approved, the study revealed six tumors with homogeneously distributed HER2 overexpression/amplification (bladder, esophageal and colorectal) and seven tumors with homogeneous EGFR amplification (vulvar, ovarian, breast, esophageal and laryngeal, and adenocarcinoma of unknown primary).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134348.RAWWcvD1SF2w0T3iYt8aTag1RpvQv8awBqak2sABjSTxE130_provenance.